FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217008429> ?p ?o ?g. }

• W3217008429 abstract "Background: Docetaxel is an important chemotherapy-agent for breast cancer treatment. One of its side-effects is weight gain, which increases the all-cause mortality rate. Considering gut microbiota is one important factor for weight regulation, we hypothesized that probiotics could be potentially used to reduce the docetaxel-related weight gain in breast cancer patients. Methods: From 10/8/2018 to 10/17/2019, 100 breast cancer (Stage I-III) patients underwent four cycles of docetaxel-based chemotherapy were enrolled and randomly assigned to receive probiotics (Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis) or placebo (supplementary material of the probiotics capsule) treatment for 84 days with three capsules per time, twice/day. The primary outcome: the changes in body weight and body-fat percentage of the patients were measured by a designated physician using a fat analyzer, and the secondary outcomes: the fasting insulin, plasma glucose, and lipids were directly obtained from the Hospital Information System (HIS); The metabolites were measured using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS); The fecal microbiome was analyzed using bacterial 16S ribosomal RNA (rRNA) gene sequence. All indicators were measured 1 day before the first cycle of docetaxel-based chemotherapy and 21 days after the last cycle of docetaxel-based chemotherapy. Results: Compared with the placebo group, the probiotic group showed significantly smaller changes in body weight (Mean [SD] 0.77 [2.58] vs. 2.70 [3.08], P = 0.03), body-fat percentage (Mean [SD] 0.04 [1.14] vs. 3.86 [11.09], P = 0.02), and low density lipoprotein (LDL) (Mean [SD]-0.05[0.68] vs. 0.39 [0.58], P = 0.002). Moreover, five of the 340 detected plasma metabolites showed significant differences between the two groups. The change of biliverdin dihydrochloride (B = -0.724, P = 0.02) was inverse correlated with weight gain. One strain of the phylum and three strains of the genus were detected to be significantly different between the two groups. Also, the changes of Bacteroides (B = -0.917, P < 0.001) and Anaerostipes (B = -0.894, P < 0.001) were inverse correlated with the change of LDL. Conclusions: Probiotics supplement during docetaxel-based chemotherapy for breast cancer treatment may help to reduce the increase in body weight, body-fat percentage, plasma LDL, and minimize the metabolic changes and gut dysbacteriosis. Clinical Trial Registration: http://www.chictr.org.cn/showproj.aspx?proj=24294, ChiCTR-INQ-17014181." @default.
• W3217008429 created "2021-12-06" @default.
• W3217008429 creator A5018411567 @default.
• W3217008429 creator A5045703368 @default.
• W3217008429 creator A5045744589 @default.
• W3217008429 creator A5049460061 @default.
• W3217008429 creator A5052434131 @default.
• W3217008429 creator A5057000014 @default.
• W3217008429 creator A5070630819 @default.
• W3217008429 creator A5078926294 @default.
• W3217008429 date "2021-12-02" @default.
• W3217008429 modified "2023-10-05" @default.
• W3217008429 title "Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients—A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial" @default.
• W3217008429 cites W111685584 @default.
• W3217008429 cites W1765879118 @default.
• W3217008429 cites W1880166481 @default.
• W3217008429 cites W1890682682 @default.
• W3217008429 cites W1962710076 @default.
• W3217008429 cites W1976673192 @default.
• W3217008429 cites W1990161943 @default.
• W3217008429 cites W2021160154 @default.
• W3217008429 cites W2032295744 @default.
• W3217008429 cites W2037308863 @default.
• W3217008429 cites W2038043025 @default.
• W3217008429 cites W2038217946 @default.
• W3217008429 cites W2051246865 @default.
• W3217008429 cites W2059786375 @default.
• W3217008429 cites W2085427914 @default.
• W3217008429 cites W2089171094 @default.
• W3217008429 cites W2102853091 @default.
• W3217008429 cites W2136538510 @default.
• W3217008429 cites W2141662760 @default.
• W3217008429 cites W2167547664 @default.
• W3217008429 cites W2202184362 @default.
• W3217008429 cites W2337388047 @default.
• W3217008429 cites W2369210319 @default.
• W3217008429 cites W2400493948 @default.
• W3217008429 cites W2409413684 @default.
• W3217008429 cites W2476364840 @default.
• W3217008429 cites W2502310207 @default.
• W3217008429 cites W2597457343 @default.
• W3217008429 cites W2735376054 @default.
• W3217008429 cites W2781525129 @default.
• W3217008429 cites W2790490049 @default.
• W3217008429 cites W2884495027 @default.
• W3217008429 cites W2898093266 @default.
• W3217008429 cites W2921246494 @default.
• W3217008429 cites W2949046669 @default.
• W3217008429 cites W2979126146 @default.
• W3217008429 cites W3044552023 @default.
• W3217008429 cites W3074645308 @default.
• W3217008429 cites W3110994100 @default.
• W3217008429 doi "https://doi.org/10.3389/fnut.2021.762929" @default.
• W3217008429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34926547" @default.
• W3217008429 hasPublicationYear "2021" @default.
• W3217008429 type Work @default.
• W3217008429 sameAs 3217008429 @default.
• W3217008429 citedByCount "4" @default.
• W3217008429 countsByYear W32170084292022 @default.
• W3217008429 countsByYear W32170084292023 @default.
• W3217008429 crossrefType "journal-article" @default.
• W3217008429 hasAuthorship W3217008429A5018411567 @default.
• W3217008429 hasAuthorship W3217008429A5045703368 @default.
• W3217008429 hasAuthorship W3217008429A5045744589 @default.
• W3217008429 hasAuthorship W3217008429A5049460061 @default.
• W3217008429 hasAuthorship W3217008429A5052434131 @default.
• W3217008429 hasAuthorship W3217008429A5057000014 @default.
• W3217008429 hasAuthorship W3217008429A5070630819 @default.
• W3217008429 hasAuthorship W3217008429A5078926294 @default.
• W3217008429 hasBestOaLocation W32170084291 @default.
• W3217008429 hasConcept C121608353 @default.
• W3217008429 hasConcept C126322002 @default.
• W3217008429 hasConcept C142724271 @default.
• W3217008429 hasConcept C143998085 @default.
• W3217008429 hasConcept C204787440 @default.
• W3217008429 hasConcept C27081682 @default.
• W3217008429 hasConcept C2776694085 @default.
• W3217008429 hasConcept C2780206646 @default.
• W3217008429 hasConcept C2780305828 @default.
• W3217008429 hasConcept C2781190966 @default.
• W3217008429 hasConcept C523546767 @default.
• W3217008429 hasConcept C530470458 @default.
• W3217008429 hasConcept C54355233 @default.
• W3217008429 hasConcept C71924100 @default.
• W3217008429 hasConcept C86803240 @default.
• W3217008429 hasConcept C90924648 @default.
• W3217008429 hasConceptScore W3217008429C121608353 @default.
• W3217008429 hasConceptScore W3217008429C126322002 @default.
• W3217008429 hasConceptScore W3217008429C142724271 @default.
• W3217008429 hasConceptScore W3217008429C143998085 @default.
• W3217008429 hasConceptScore W3217008429C204787440 @default.
• W3217008429 hasConceptScore W3217008429C27081682 @default.
• W3217008429 hasConceptScore W3217008429C2776694085 @default.
• W3217008429 hasConceptScore W3217008429C2780206646 @default.
• W3217008429 hasConceptScore W3217008429C2780305828 @default.
• W3217008429 hasConceptScore W3217008429C2781190966 @default.
• W3217008429 hasConceptScore W3217008429C523546767 @default.
• W3217008429 hasConceptScore W3217008429C530470458 @default.
• W3217008429 hasConceptScore W3217008429C54355233 @default.
• W3217008429 hasConceptScore W3217008429C71924100 @default.

• next